Scripps’ outside phone carrier is experiencing an outage that is affecting some phone lines and faxes. Temporary phone numbers are listed on our Contact Us page. We apologize for any inconvenience and will provide updates as they are available.

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.

×

Novel Liver Cancer Clinical Trial to Begin at Scripps MD Anderson Cancer Center

Scripps oncologist discusses new liver cancer drug on KUSI

A San Diego news anchor and Scripps oncologist smile for a photo during a news segment recording.

KUSI anchor Logan Byrnes and Dr. Darren Sigal, GI oncology, Scripps MD Anderson Cancer Center, Scripps Clinic

Scripps oncologist discusses new liver cancer drug on KUSI

Darren Sigal, MD, program director of gastrointestinal oncology at Scripps MD Anderson Cancer Center, recently appeared on KUSI to discuss a new liver cancer drug that is being developed at Scripps Research.


The number of new liver cancer cases in the United States has tripled since the 1980s. Today, liver cancer ranks as the fifth-most common cause of cancer-related death in the U.S.


Watch the segment on KUSI:

Watch the segment on KUSI:

Media Contact

Steve Carpowich
858-678-7183